Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection

Journal of Gene Medicine

Volumn 11, Issue 1, 2009, Pages 92-99

  Hlawaty, Hanna ^a,b   San Juan, Aurélie ^a   Jacob, Marie Paule ^a   Vranckx, Roger ^a   Letourmeur, Didier ^a,b   Feldman, Laurent J ^a,c  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Balloon injury; Intimal hyperplasia of hypercholesterolemic rabbits; Metalloproteinases; SiRNA transfection in vivo

Indexed keywords

GELATINASE A; GELATINASE B; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON OCCLUSION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; ZYMOGRAPHY; ANIMAL; CAROTID ARTERY; CAROTID ARTERY INJURY; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; MALE; METABOLISM; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RNA INTERFERENCE;

ORYCTOLAGUS CUNICULUS;

ANGIOPLASTY, BALLOON; ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RABBITS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

EID: 59449098256     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1275     Document Type: Article

References (41)

1. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004; 3: 318-329.
2. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737-747.
3. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
4. Bennett MR, Schwartz SM. Antisense therapy for angioplasty restenosis. Some critical considerations. Circulation 1995; 92: 1981-93.
5. Silverman SK. Deoxyribozymes: DNA catalysts for bioorganic chemistry. Org Biomol Chem 2004; 2: 2701-2706.
6. Grassi G, Schneider A, Engel S, Racchi G, Kandolf R, Kuhn A. Hammerhead ribozymes targeted against cyclin E and E2F1 cooperate to down-regulate coronary smooth muscle cell proliferation. J Gene Med 2005; 7: 1223-1234.
7. Chetty C, Bhoopathi P, Joseph P, Chittivelu S, Rao JS, Lakka S. Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 2006; 5: 2289-2299.
8. Song E, Lee SK, Wang J, et al.. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-351.
9. McCaffrey AP, Nakai H, Pandey K, et al.. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003; 21: 639-644.
10. Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther 2006; 13: 644-670.
11. Soutschek J, Akinc A, Bramlage B, et al.. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432: 173-178.
12. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-222.
13. Santel A, Aleku M, Keil O, et al.. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther 2006; 13: 1222-1234.
14. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004; 3: 318-329.
15. Akaneya Y, Jiang B, Tsumoto T. RNAi-induced gene silencing by local electroporation in targeting brain region. J Neurophysiol 2005; 93: 594-602.
16. Reich SJ, Fosnot J, Kuroki A, et al.. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in amouse model. Mol Vis 2003; 9: 210-216.
17. Santel A, Aleku M, Keil O, et al.. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther 2006; 13: 1360-1370.
18. Corteling RL, Brett SE, Yin H, Zheng XL, Walsh MP, Welsh DG. The functional consequence of RhoA knockdown by RNA interference in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2007; 293: H440-447.
19. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503.
20. Deux JF, Meddahi-Pelle A, Le Blanche AF, et al.. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model. Arterioscler Thromb Vasc Biol 2002; 22: 1604-1609.
21. Feldman LJ, Aguirre L, Ziol M, et al.. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000; 101: 908-916.
22. Gonzalez W, Fontaine V, Pueyo ME, et al.. Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 2000; 36: 103-109.
23. Grote K, Flach I, Luchtefeld M, et al.. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003; 92: 80-86.
24. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol 2000; 192: 105-112.
25. Feldman LJ, Mazighi M, Scheuble A, et al.. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 2001; 103: 3117-3122.
26. Scherer LJ, Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol 2003; 21: 1457-1465.
27. Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002; 296: 1000-1004.
28. Macejak DG, Jensen KL, Jamison SF, et al.. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 2000; 31: 769-776.
29. Chen Y, Lin MC, Yao H, et al.. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007; 46: 200-208.
30. Kumar P, WuH, McBride JL, et al.. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007; 448: 39-43.
31. St George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003; 10: 1135-1141.
32. Feldman LJ, Steg PG, Zheng LP, et al.. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest 1995; 95: 2662-2671.
33. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005; 12: 461-466.
34. Hlawaty H, San Juan A, Jacob MP, Vranckx R, Letourneur D, Feldman L. Inhibition of MMP2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2007; 293: H3593-H3601.
35. Takahashi H, Letourneur D, Grainger DW. Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules 2007; 8: 3281-3293.
36. Zender L, Hutker S, Liedtke C, et al.. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 2003; 100: 7797-7802.
37. Schiffelers RM, Mixson AJ, Ansari AM, et al.. Transporting silence: design of carriers for siRNA to angiogenic endothelium. J Control Release 2005; 109: 5-14.
38. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006; 354: 483-495.
39. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002; 8: 1249-1256.
40. Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 2006; 44: 633-641.
41. Kusaba K, Kai H, Koga M, et al.. Inhibition of intrinsic interferon-gamma function prevents neointima formation after balloon injury. Hypertension 2007; 49: 909-915.